as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹161.24
Change
-8.11 (-4.79%)
Open
₹166.0
Prev. Close
₹169.35
Day High
₹166.0
Day Low
₹158.82
Volume Analysis
Traded
20,306,471
Delivered
6,228,771
Delivery %
30.67%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Low return on equity (2.46%)
- •Below-average fundamentals quality score (48/100)
Opportunities (2)
- •Strong 3-year revenue growth (19.3%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹172.4 | ₹169.2 | ₹165.22 | ₹162.02 | ₹158.04 | ₹154.84 | ₹150.86 |
| Fibonacci | ₹169.2 | ₹166.46 | ₹164.76 | ₹162.02 | ₹159.28 | ₹157.58 | ₹154.84 |
| Camarilla | ₹163.21 | ₹162.56 | ₹161.9 | ₹162.02 | ₹160.58 | ₹159.92 | ₹159.27 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-31.42%
1 Week
-8.33%
1 Month
+1.78%
3 Months
+2.76%
6 Months
+12.88%
1 Year
-32.59%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹33.89
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
2.38%
Net margin 5.35% × asset turnover 0.19x × equity multiplier 2.34x
Company Overview
Sector
Financial Services
Market Cap
₹20,374 Cr
P/E (TTM)
126.0
ROE
2.46%
Book Value
₹52.1
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Pine Labs Limited scores weakly on TopFund's composite fundamentals check within the Financial Services sector, at 48/100. The strongest factor is Growth (98/100), while Corporate Governance (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (2.46%); below-average fundamentals quality score (48/100). Strong 3-year revenue growth (19.3%).
TopFund Score — Fundamentals Quality
48/100 — WeakData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has delivered good profit growth of 32.3% CAGR over last 5 years
- −Stock is trading at 3.38 times its book value
- −Company has a low return on equity of -2.94% over last 3 years.
- −Company's cost of borrowing seems high
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Audio/video recording of October 29, 2026 analyst and investor conference call uploaded on website.
CARE report for quarter ended Sep. 30, 2026 shows nil deviation in IPO proceeds utilization.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 552 | 602 | 599 | 616 | 650 | 744 | 701 | 737 | 806 |
| Expenses + | 519 | 525 | 542 | 571 | 575 | 612 | 594 | 642 | 680 |
| Operating Profit | 32 | 77 | 57 | 45 | 75 | 132 | 106 | 95 | 126 |
| OPM % | 6.0% | 13.0% | 9.0% | 7.0% | 12.0% | 18.0% | 15.0% | 13.0% | 16.0% |
| Other Income + | 22 | -30 | 12 | 37 | 23 | 23 | 50 | 29 | 26 |
| Interest | 18 | 22 | 22 | 21 | 21 | 24 | 17 | 13 | 14 |
| Depreciation | 75 | 76 | 69 | 65 | 66 | 68 | 71 | 73 | 76 |
| Profit before tax | -38 | -51 | -22 | -5 | 11 | 63 | 68 | 38 | 61 |
| Tax % | -16.0% | 11.0% | 30.0% | -199.0% | 47.0% | 32.0% | 13.0% | 48.0% | 37.0% |
| Net Profit + | -32 | -57 | -29 | 5 | 6 | 42 | 59 | 20 | 39 |
| EPS in Rs | 0 | -1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Raw PDF | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | 18 | 24 | 17 | 20 | 24 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 848 | 670 | 932 | 1,598 | 1,770 | 2,274 | 2,711 | 2,988 |
| Expenses + | 760 | 560 | 820 | 1,592 | 1,794 | 2,056 | 2,352 | 2,529 |
| Operating Profit | 87 | 110 | 112 | 5 | -25 | 218 | 358 | 459 |
| OPM % | 10.0% | 16.0% | 12.0% | 0.3% | -1.4% | 10.0% | 13.0% | 15.0% |
| Other Income + | 18 | 13 | 25 | 56 | 55 | 16 | 133 | 128 |
| Interest | 18 | 22 | 24 | 36 | 64 | 79 | 84 | 68 |
| Depreciation | 155 | 175 | 189 | 315 | 363 | 292 | 270 | 288 |
| Profit before tax | -68 | -74 | -75 | -289 | -398 | -136 | 137 | 230 |
| Tax % | -30.0% | -25.0% | -70.0% | -8.0% | -14.0% | 7.0% | 18.0% | — |
| Net Profit + | -47 | -56 | -23 | -265 | -342 | -145 | 113 | 160 |
| EPS in Rs | -1 | -1 | 0 | -3 | -4 | -2 | 1 | 1 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | — | -21 | 39 | 71 | 11 | 29 | 19 | 21 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Reserves | 1,035 | 1,178 | 1,900 | 3,664 | 3,466 | 3,431 | 5,781 | 5,904 |
| Borrowings + | 176 | 191 | 236 | 514 | 730 | 1,046 | 441 | 353 |
| Other Liabilities + | 2,225 | 3,185 | 4,111 | 5,141 | 5,422 | 6,222 | 6,952 | 7,711 |
| Total Liabilities | 3,448 | 4,567 | 6,260 | 9,318 | 9,618 | 10,698 | 13,288 | 14,083 |
| Fixed Assets + | 1,017 | 980 | 1,019 | 2,103 | 1,920 | 1,825 | 1,856 | 2,141 |
| CWIP | 52 | 48 | 122 | 269 | 222 | 160 | 148 | 64 |
| Investments | 40 | 34 | 50 | 18 | 21 | 30 | 28 | 32 |
| Other Assets + | 2,338 | 3,505 | 5,070 | 6,928 | 7,455 | 8,683 | 11,256 | 11,846 |
| Total Assets | 3,448 | 4,567 | 6,260 | 9,318 | 9,618 | 10,698 | 13,288 | 14,083 |
| Equity Capital | 12 | 13 | 14 | 0 | 0 | 0 | 115 | 115 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 11 | 111 | -79 | -152 | -229 | 50 | 395 |
| Cash from Investing Activity + | 112 | -260 | -443 | -441 | -22 | -159 | -1,339 |
| Cash from Financing Activity + | 1,431 | 823 | 1,644 | 2 | -220 | -201 | 1,972 |
| Net Cash Flow | 1,554 | 674 | 1,122 | -591 | -471 | -310 | 1,029 |
| Free Cash Flow | -156 | -54 | -407 | -517 | -486 | -99 | 161 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 86 | 114 | -25 | -1,258 | 872 | 5 | 112 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Public | 83.51% | 83.39% | 65.68% | 57.24% |
| FII | 5.23% | 4.8% | 9.49% | 13.18% |
| DII | 11.26% | 11.81% | 24.82% | 29.57% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Financial Services — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Pine Labs Limited (this stock) | 20,374 | 126.0 | 3.38 | 2.46% |
| Aadhar Housing Finance L | 18,954 | 15.9 | 2.31 | 15.9% |
| Computer Age Mngt Ser Ltd | 17,952 | 35.1 | 12.47 | 37.4% |
| Creditaccess Grameen Ltd | 17,576 | 11.1 | 1.97 | 10.5% |
| Capri Global Capital Ltd | 23,236 | 17.7 | 2.93 | 16.5% |
| Sammaan Capital Limited | 17,168 | — | 0.83 | -3.21% |
| IFCI Ltd | 16,619 | 91.0 | 1.46 | 1.97% |
Which Mutual Funds Hold Pine Labs Limited?
Frequently Asked Questions about Pine Labs Limited
Pine Labs Limited (PINELABS) closed at ₹161.24 on NSE on 19 November 2026, down 8.11 (4.79%) from the previous close.
Pine Labs Limited trades on the NSE (National Stock Exchange of India) under the symbol PINELABS.
Pine Labs Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 126.0.
Pine Labs Limited has a dividend yield of 0.0%.
Pine Labs Limited's 52-week high is ₹262.0 and its 52-week low is ₹135.0.
Pine Labs Limited has a market capitalisation of ₹20,374 crore.
Pine Labs Limited has a TopFund Quality Score of 48/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Pine Labs Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.